CN104761600B - Synthesis and uses of beta-1-imidazole-2,3,4,6-tetrahydroxy-D-glucopyranose bromide - Google Patents

Synthesis and uses of beta-1-imidazole-2,3,4,6-tetrahydroxy-D-glucopyranose bromide Download PDF

Info

Publication number
CN104761600B
CN104761600B CN201510103297.9A CN201510103297A CN104761600B CN 104761600 B CN104761600 B CN 104761600B CN 201510103297 A CN201510103297 A CN 201510103297A CN 104761600 B CN104761600 B CN 104761600B
Authority
CN
China
Prior art keywords
compound
reaction
bromo
imidazoles
tetrahydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510103297.9A
Other languages
Chinese (zh)
Other versions
CN104761600A (en
Inventor
宛瑜
张潇潇
王超
崔浩
吴翚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangxi Dexing PARCHN Sodium VC Co., Ltd.
Original Assignee
Jiangsu Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Normal University filed Critical Jiangsu Normal University
Priority to CN201510103297.9A priority Critical patent/CN104761600B/en
Publication of CN104761600A publication Critical patent/CN104761600A/en
Application granted granted Critical
Publication of CN104761600B publication Critical patent/CN104761600B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)

Abstract

The invention relates to synthesis and uses of beta-1-imidazole-2,3,4,6-tetrahydroxy-D-glucopyranose bromide and belongs to glucopyranose chemical synthesis by multi-component reactions and uses of the glucopyranose. The synthesis includes: 1) subjecting glucose 1 that is adopted as a raw material to acetylation to obtain a compound 2; 2) performing bromination by adopting the compound 2 as a raw material to obtain a compound 3; 3) reacting the compound 3 with 1-methylimidazole to obtain a compound 4; and 4) hydrolyzing the compound 4 under alkaline conditions to obtain a target compound 5 that is the beta-1-imidazole-2,3,4,6-tetrahydroxy-D-glucopyranose bromide. Ketone-ketone cross Aldol reactions of isatin and derivatives thereof and low-activity ketones are catalyzed by adopting the target compound 5 as an efficient catalyst to synthesize a series of 3-alkyl-3-hydroxy-2-ketone derivatives with potential medicinal value. The synthesis and the uses are advantageous in that: the low-activity ketones which cannot be catalyzed by other catalysts can react directly, thus broadening the range of reaction substrates, a method and operation are simple, reaction time is short, and the yield is high. Reactions are green, economical and efficient.

Description

The synthesis of bromo β -1- imidazoles -2,3,4,6- tetrahydroxy-D- glucopyranoses and purposes
Technical field
The present invention relates to a kind of many component reactive chemistry synthesizing pyran glucose and application thereof, particularly a kind of bromo β -1- The synthesis of imidazoles -2,3,4,6- tetrahydroxy-D- glucopyranoses and purposes.
Background technology
It is most important a kind of C-C bond formeds reaction in modern organic synthesis that Aldol reactions are aldol reaction.Mesh Before, aldehyde-aldehyde for being carried out by enamine intermediates, aldehyde -one Aldol are reacted to a big pillar of modern organic synthesis chemistry.So And, due to not activated ketone α-H activity it is relatively low, it is difficult to there is intermolecular ketone -one cross-aldol condensation, therefore, point Ketone -one cross-aldol condensation is a vitochemical significant challenge between son, and relevant report is considerably less.Want by efficient Intermolecular ketone -one cross-aldol condensation obtain with potential medical value 3- alkyl -3- hydroxyl -2- ketone derivatives, Must high, the selectively strong new catalyst of synthesis catalytic activity.
D-Glucose as being distributed widest natural monosaccharide in nature, for it understanding and effect already by people It is known.But its research in terms of chemical synthesis as monose never causes enough attention.Glucose is used as polysaccharide Basic structural unit, not only cheap, aboundresources, itself small-molecular-weight, recyclability and water solubility are all caused Glucose is seen as preparing the desirable feedstock of organic micromolecule catalyst.
Nitrogen heterocyclic ring Cabbeen has special space and electronic structure, is a class bipolarity isoelectronic species, as catalyst, Its avtive spot is more, and catalysis activity is high.
The combination of sugar and N-heterocyclic carbine has the advantage of Cabbeen and sugar concurrently containing sugared N-heterocyclic carbine, both has to organic reaction There is higher catalytic activity, there is stronger surface-active again, the solubility of organic compound can be improved, it is great in organic catalysis field Development volue.
The content of the invention
The invention aims to provide a kind of containing sugared N-heterocyclic carbine bromo β -1- imidazoles -2,3,4,6- tetrahydroxy-D- The synthesis of glucopyranose and purposes, the intermolecular ketone -one cross-aldol condensation of solution is difficult to be occurred, and is difficult to obtain to have and is dived In the problem of the 3- alkyl -3- hydroxyl -2- ketone derivatives of medical value.
The object of the present invention is achieved like this:The conjunction of bromo β -1- imidazoles -2,3,4,6- tetrahydroxy-D- glucopyranoses Into, including:1) acetylation is carried out as raw material with glucose 1 and obtains compound 2;2) chemical combination is obtained by raw material Jing bromos of compound 2 Thing 3;3) compound 3 and the reaction of N-methyl imidazoles are obtained into compound 4;4) compound 4 is hydrolyzed in the basic conditions and obtains mesh Mark compound 5, i.e. bromo β -1- imidazoles -2,3,4,6- tetrahydroxy-D- glucopyranoses are comprised the following steps that:
1) acetylation is carried out as raw material with glucose 1 and generates compound 2, described compound 2 is 1,2,3,4,6- five-second Acyl group-glucopyranose, its reaction equation is as follows:
Sequentially add in the neck round-bottom flasks of 500mL two DEXTROSE ANHYDROUS of 5.0mmol, the acetic anhydride of 50.0mmol and 30min is stirred in the silicon sulfonic acid SSA of 0.08g, argon gas protection under room temperature, reaction is complete, directly carries out next step reaction;
2) compound 3 is obtained by raw material Jing bromos of compound 2, described compound 3 is bromo- 2,3,4, the 6- tetra--acetyl of 1- Base glucopyranose, its reaction equation is as follows:
Under argon gas protection ice bath, the glacial acetic acid of 20mL is added in system, be passed through brand-new bromination hydrogen, gas is passed through 1h React complete afterwards, the product in system is poured in frozen water, extracted with dichloromethane, organic phase saturated sodium thiosulfate solution Washing, point liquid, organic phase saturated sodium bicarbonate solution is washed to neutrality, is washed with water 2-3 time, separates organic phase, organic phase With anhydrous sodium sulfate drying, drier is filtered, decompression is spin-dried for obtaining colorless viscous shape liquid, uses VEther:VPetroleum ether=1:1 recrystallization, obtains Compound 3;
3) compound 3 and N-methyl imidazoles reaction obtains compound 4, and described compound 4 is bromo β -1- imidazoles -2, and 3, 4,6- tetra-acetylated-D- glucopyranoses, its reaction equation is as follows:
The N- methylimidazoles of the compound 3 of 10mmol and 20mmol are placed in 50mL round-bottomed flasks, 1mL acetonitriles are added, 2h is stirred at room temperature, thick white shape solid is obtained, is washed with acetone, suction filtration obtains compound as white solid 4;
4) compound 4 is hydrolyzed in the basic conditions and obtains target product i.e. compound 5, described compound 5 is bromo β -1- imidazoles -2,3,4,6- tetrahydroxy-D- glucopyranoses, its reaction equation is as follows:
The compound 4 of 2mmol is placed in the neck bottles of 50mL two, under argon gas protection 10mL absolute methanols and 10mL are sequentially added Anhydrous tetrahydro furan, adds 0.5mmol Anhydrous potassium carbonates after stirring;React under room temperature ar gas environment to terminating, course of reaction by Thin-layer chromatography (TLC) tracing detection;Suction filtration obtains light yellow liquid, and decompression boils off excess of solvent, obtains pale yellow oily liquid chemical combination Thing 5;Yellow oil;IR(KBr)ν:3364,3152,1420,1364,1310,1177,1101,1074,1020cm-11H NMR(400MHz,DMSO-d6)(δ,ppm):3.15 (s, 1H), 3.25 (t, J=8.9Hz, 2H), 3.37 (t, J=8.8Hz, 2H), 3.42-3.51 (m, 4H), 3.71 (d, J=10.8Hz, 1H), 3.90 (s, 3H), 5.40 (d, J=8.8Hz, 1H), 7.79 (d, J=1.8Hz, 1H), 7.92 (d, J=1.9Hz, 1H), 9.45 (s, 1H);13C NMR(100MHz,DMSO-d6):δ136.2, 123.6,120.8,87.0,80.1,76.1,72.8,69.1,60.5,36.0;HRMS(ESI)m/z:calc.for C10H17N2O5 [M-Br]+found(expected):245.1178(245.1132).
The ketone -one of the described catalysis of target product 5 intersects Aldol reaction expressions:
R in compound 8 in formula1Group includes H, 5-F, 5-Cl, 5-Br, 5-CH3, 5-CH3O, 5,7- (CH3)2, 5-NO2; R1Group includes-C6H5,-CH3
By [Bmim-G '] of the Isatine derivatives 6,20mol% of 0.1mmol+[Br]-In being placed in 50mL round-bottomed flasks, add Stir 10 minutes at 50 DEG C of 2mL ethanol, carbonyls 7 is added in system, described compound 7 is 3.0mmol acetophenones Or 8.0mmol acetone, continuing to stir to reacting complete, course of reaction is by thin-layer chromatography (TLC) tracing detection;Decompression boils off system Middle excess of solvent, crude product passes through column chromatography (VPetroleum ether:VEthyl acetate=4:1-1:2.5 gradient elutions) obtain purified product 8.
Bromo β -1- imidazoles -2, the purposes of 3,4,6- tetrahydroxy-D- glucopyranoses, by bromo β -1- imidazoles -2,3,4, 6- tetrahydroxy-D- glucopyranoses intersect as catalyst, the ketone -one that catalysis isatin and its derivative are participated in low activity ketone Aldol reacts, serial 3- alkyl -3- hydroxyl -2- ketone derivatives of the synthesis with potential medical value.
Beneficial effect and advantage:The synthesis of the bromo β -1- imidazoles -2,3,4,6- tetrahydroxy-D- glucopyranoses of the present invention Method is, containing sugared N-heterocyclic carbine bromo β -1- imidazoles -2, the synthetic method of 3,4,6- tetrahydroxy-D- glucopyranoses, to be made The ketone -one that isatin and its derivative participate in low activity ketone being successfully catalyzed for catalyst and having intersected Aldol reactions, having synthesized one has been 3- alkyl -3- hydroxyl -2- ketone derivatives of the row with potential medical value.
1st, the reaction is had containing sugared N-heterocyclic carbine bromo β -1- imidazoles -2,3,4,6- tetrahydroxy-D- glucopyranoses Well catalysis activity, quickly can in high yield obtain product 8, and described product 8 is derivative for 3- alkyl -3- hydroxyl -2- ketone Thing.
2nd, the yield of reaction is universal higher, shows the universality of substrate.
3rd, not activated low activity ketone can obtain product with higher yields, show the high catalytic activity of the catalyst.
4th, reaction condition is gentle, and simple to operate, the reaction time is especially short, and yield is high, and post processing is easy.
5th, environmental protection, economical and efficient, with high actual application value are reacted.
Specific embodiment
Bromo β -1- imidazoles -2, the synthesis of 3,4,6- tetrahydroxy-D- glucopyranoses, including:1) with glucose 1 as raw material Carry out acetylation and obtain compound 2;2) compound 3 is obtained by raw material Jing bromos of compound 2;3) by compound 3 and N-methyl miaow Azoles reaction obtains compound 4;4) in the basic conditions by compound 4 hydrolysis obtain target compound 5, i.e. bromo β -1- imidazoles - 2,3,4,6- tetrahydroxy-D- glucopyranoses, comprise the following steps that:
1) acetylation is carried out as raw material with glucose 1 and generates compound 2, described compound 2 is 1,2,3,4,6- five-second Acyl group-glucopyranose, its reaction equation is as follows:
Sequentially add in the neck round-bottom flasks of 500mL two DEXTROSE ANHYDROUS of 5.0mmol, the acetic anhydride of 50.0mmol and 30min is stirred in the silicon sulfonic acid SSA of 0.08g, argon gas protection under room temperature, reaction is complete, directly carries out next step reaction;
2) compound 3 is obtained by raw material Jing bromos of compound 2, described compound 3 is bromo- 2,3,4, the 6- tetra--acetyl of 1- Base glucopyranose, its reaction equation is as follows:
Under argon gas protection ice bath, the glacial acetic acid of 20mL is added in system, be passed through brand-new bromination hydrogen, gas is passed through 1h React complete afterwards, the product in system is poured in frozen water, extracted with dichloromethane, organic phase saturated sodium thiosulfate solution Washing, point liquid, organic phase saturated sodium bicarbonate solution is washed to neutrality, is washed with water 2-3 time, separates organic phase, organic phase With anhydrous sodium sulfate drying, drier is filtered, decompression is spin-dried for obtaining colorless viscous shape liquid, uses VEther:VPetroleum ether=1:1 recrystallization, obtains Compound 3;
3) compound 3 and N-methyl imidazoles reaction obtains compound 4, and described compound 4 is bromo β -1- imidazoles -2, and 3, 4,6- tetra-acetylated-D- glucopyranoses, its reaction equation is as follows:
The N- methylimidazoles of the compound 3 of 10mmol and 20mmol are placed in 50mL round-bottomed flasks, 1mL acetonitriles are added, 2h is stirred at room temperature, thick white shape solid is obtained, is washed with acetone, suction filtration obtains compound as white solid 4;
4) compound 4 is hydrolyzed in the basic conditions and obtains target product i.e. compound 5, described compound 5 is bromo β -1- imidazoles -2,3,4,6- tetrahydroxy-D- glucopyranoses, its reaction equation is as follows:
The compound 4 of 2mmol is placed in the neck bottles of 50mL two, under argon gas protection 10mL absolute methanols and 10mL are sequentially added Anhydrous tetrahydro furan, adds 0.5mmol Anhydrous potassium carbonates after stirring;React under room temperature ar gas environment to terminating, course of reaction by Thin-layer chromatography (TLC) tracing detection;Suction filtration obtains light yellow liquid, and decompression boils off excess of solvent, obtains pale yellow oily liquid chemical combination Thing 5;Yellow oil;IR(KBr)ν:3364,3152,1420,1364,1310,1177,1101,1074,1020cm-11H NMR(400MHz,DMSO-d6)(δ,ppm):3.15 (s, 1H), 3.25 (t, J=8.9Hz, 2H), 3.37 (t, J=8.8Hz, 2H), 3.42-3.51 (m, 4H), 3.71 (d, J=10.8Hz, 1H), 3.90 (s, 3H), 5.40 (d, J=8.8Hz, 1H), 7.79 (d, J=1.8Hz, 1H), 7.92 (d, J=1.9Hz, 1H), 9.45 (s, 1H);13C NMR(100MHz,DMSO-d6):δ136.2, 123.6,120.8,87.0,80.1,76.1,72.8,69.1,60.5,36.0;HRMS(ESI)m/z:calc.for C10H17N2O5 [M-Br]+found(expected):245.1178(245.1132).
The ketone -one of the described catalysis of target product 5 intersects Aldol reaction expressions:
R in compound 8 in formula1Group includes H, 5-F, 5-Cl, 5-Br, 5-CH3, 5-CH3O, 5,7- (CH3)2,
5-NO2;R1Group includes-C6H5,-CH3
By [Bmim-G '] of the Isatine derivatives 6,20mol% of 0.1mmol+[Br]-In being placed in 50mL round-bottomed flasks, add Stir 10 minutes at 50 DEG C of 2mL ethanol, carbonyls 7 is added in system, described compound 7 is 3.0mmol acetophenones Or 8.0mmol acetone, continuing to stir to reacting complete, course of reaction is by thin-layer chromatography (TLC) tracing detection;Decompression boils off system Middle excess of solvent, crude product passes through column chromatography (VPetroleum ether:VEthyl acetate=4:1-1:2.5 gradient elutions) obtain purified product 8.
The synthesis of the product 8 of table 1.
Bromo β -1- imidazoles -2, the purposes of 3,4,6- tetrahydroxy-D- glucopyranoses, by bromo β -1- imidazoles -2,3,4, 6- tetrahydroxy-D- glucopyranoses intersect as catalyst, the ketone -one that catalysis isatin and its derivative are participated in low activity ketone Aldol reacts, serial 3- alkyl -3- hydroxyl -2- ketone derivatives of the synthesis with potential medical value.
Embodiment 1:By taking 3- hydroxyl -3- (2- oxo -2- phenylethyls) indol-2-one (8a) as an example:
Isatin 6a (0.1mmol), target product 5 (20mol%) are placed in 50mL round-bottomed flasks, add 2mL ethanol in Stir 10 minutes at 50 DEG C, acetophenone (3.0mmol acetophenones or 8.0mmol acetone) is added in system, continue to stir to anti- Should completely (TLC tracking), decompression boils off excess of solvent in system, and crude product passes through column chromatography (VPetroleum ether:VEthyl acetate=4:1-1:2.5 Gradient elution) obtain sterling 8a.
(brs, 1H), 6.79-6.87 (m, 2H), 7.14-7.18 (m, 1H), 7.26 (d, J=7.6Hz, 1H), 7.49 (t, J =8.0Hz, 2H), 7.60-7.64 (m, 1H), 7.87-7.89 (m, 2H), 10.26 (br s, 1H);13C NMR(100MHz, DMSO-d6):δ196.4,178.3,142.9,136.1,133.4,131.7,128.9,128.7,127.9,123.6,121.1, 109.4,72.9,45.7.HRMS(ESI)m/z:calc.for C16H12NO3[M-H]-:266.0817;found:266.0790.

Claims (3)

1. a kind of bromo β -1- imidazoles -2, the synthesis of 3,4,6- tetrahydroxy-D- glucopyranoses, is characterized in that:Bromo β -1- miaows Azoles -2, the synthesis of 3,4,6- tetrahydroxy-D- glucopyranoses, including:1) acetylation is carried out as raw material with glucose 1 and obtains chemical combination Thing 2;2) compound 3 is obtained by raw material Jing bromos of compound 2;3) compound 3 and the reaction of N-methyl imidazoles are obtained into compound 4; 4) compound 4 is hydrolyzed in the basic conditions and obtains target compound 5, i.e. bromo β -1- imidazoles -2,3,4,6- tetrahydroxy-D- pyrroles Glucopyranoside, comprises the following steps that:
1) acetylation is carried out as raw material with glucose 1 and generates compound 2, described compound 2 is 1,2,3,4,6- five-acetyl Base-glucopyranose, its reaction equation is as follows:
The DEXTROSE ANHYDROUS of 5.0mmol, the acetic anhydride of 50.0mmol and 0.08g are sequentially added in the neck round-bottom flasks of 500mL two Silicon sulfonic acid SSA, argon gas protection stirs 30min under room temperature, reaction is complete, directly carries out next step reaction;
2) compound 3 is obtained by raw material Jing bromos of compound 2, described compound 3 is bromo- 2,3,4, the 6- tetra--acetyl group pyrroles of 1- Glucopyranoside, its reaction equation is as follows:
Under argon gas protection ice bath, the glacial acetic acid of 20mL is added in system, be passed through brand-new bromination hydrogen, gas is passed through after 1h instead Should be complete, the product in system is poured in frozen water, extracted with dichloromethane, organic phase saturated sodium thiosulfate solution is washed Wash, point liquid, organic phase saturated sodium bicarbonate solution is washed to neutrality, is washed with water 2-3 time, separate organic phase, organic phase is used Anhydrous sodium sulfate drying, filters drier, and decompression is spin-dried for obtaining colorless viscous shape liquid, uses VEther:VPetroleum ether=1:1 recrystallization, must change Compound 3;
3) compound 3 and N-methyl imidazoles reaction obtains compound 4, and described compound 4 is bromo β -1- imidazoles -2, and 3,4,6- Tetra-acetylated-D- glucopyranoses, its reaction equation is as follows:
The N- methylimidazoles of the compound 3 of 10mmol and 20mmol are placed in 50mL round-bottomed flasks, 1mL acetonitriles are added, in room The lower stirring 2h of temperature, obtains thick white shape solid, is washed with acetone, and suction filtration obtains compound as white solid 4;
4) compound 4 is hydrolyzed in the basic conditions and obtains target product i.e. compound 5, described compound 5 is bromo β -1- Imidazoles -2,3,4,6- tetrahydroxy-D- glucopyranoses, its reaction equation is as follows:
The compound 4 of 2mmol is placed in the neck bottles of 50mL two, 10mL absolute methanols is sequentially added under argon gas protection and 10mL is anhydrous Tetrahydrofuran, adds 0.5mmol Anhydrous potassium carbonates after stirring;React under room temperature ar gas environment to terminating, course of reaction is by thin layer Chromatography (TLC) tracing detection;Suction filtration obtains light yellow liquid, and decompression boils off excess of solvent, obtains pale yellow oily liquid compound 5.
2. bromo β -1- imidazoles -2 according to claim 1, the synthesis of 3,4,6- tetrahydroxy-D- glucopyranoses, it is special Levying is:The ketone -one of the described catalysis of target product 5 intersects Aldol reaction expressions:
R in compound 8 in formula1Group includes H, 5-F, 5-Cl, 5-Br, 5-CH3, 5-CH3O, 5,7- (CH3)2, 5-NO2;R2Take Dai Ji includes-C6H5,-CH3
By [Bmim-G '] of the Isatine derivatives 6,20mol% of 0.1mmol+[Br]-In being placed in 50mL round-bottomed flasks, 2mL is added Stir 10 minutes at 50 DEG C of ethanol, add carbonyls 7 in system, described compound 7 be 3.0mmol acetophenones or 8.0mmol acetone, continues to stir to reacting complete, and course of reaction is by thin-layer chromatography (TLC) tracing detection;Decompression is boiled off in system Excess of solvent, crude product obtains purified product 8 by column chromatography, and described column chromatography is:VPetroleum ether:VEthyl acetate=4:1-1:2.5 gradient Drip washing.
3. bromo β -1- imidazoles -2 that a kind of claim 1 synthesizes, the purposes of 3,4,6- tetrahydroxy-D- glucopyranoses, it is special Levying is:Bromo β -1- imidazoles -2, the purposes of 3,4,6- tetrahydroxy-D- glucopyranoses, by bromo β -1- imidazoles -2,3,4,6- tetra- Hydroxyl-D- glucopyranoses intersect Aldol as catalyst, the ketone -one that catalysis isatin and its derivative are participated in low activity ketone Reaction, serial 3- alkyl -3- hydroxyl -2- ketone derivatives of the synthesis with potential medical value.
CN201510103297.9A 2015-03-09 2015-03-09 Synthesis and uses of beta-1-imidazole-2,3,4,6-tetrahydroxy-D-glucopyranose bromide Active CN104761600B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510103297.9A CN104761600B (en) 2015-03-09 2015-03-09 Synthesis and uses of beta-1-imidazole-2,3,4,6-tetrahydroxy-D-glucopyranose bromide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510103297.9A CN104761600B (en) 2015-03-09 2015-03-09 Synthesis and uses of beta-1-imidazole-2,3,4,6-tetrahydroxy-D-glucopyranose bromide

Publications (2)

Publication Number Publication Date
CN104761600A CN104761600A (en) 2015-07-08
CN104761600B true CN104761600B (en) 2017-04-26

Family

ID=53643734

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510103297.9A Active CN104761600B (en) 2015-03-09 2015-03-09 Synthesis and uses of beta-1-imidazole-2,3,4,6-tetrahydroxy-D-glucopyranose bromide

Country Status (1)

Country Link
CN (1) CN104761600B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108586558A (en) * 2018-07-02 2018-09-28 赣南师范大学 Carbohydrate alkyl bond connects imidazole type N-heterocyclic carbine palladium complex and its preparation method and application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102617657A (en) * 2012-02-22 2012-08-01 徐州师范大学 Method and reaction device for synthesizing 1-bromo-2,3,4,6-tetra-acetyl glucopyranose

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102617657A (en) * 2012-02-22 2012-08-01 徐州师范大学 Method and reaction device for synthesizing 1-bromo-2,3,4,6-tetra-acetyl glucopyranose

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Carbohydrate-containing N-heterocyclic carbene complexes.;Friederike Tewes, et al.,;《Journal of Organometallic Chemistry》;20070508;第692卷;第4593–4602页. *
Ruthenium Olefin Metathesis Catalysts Bearing Carbohydrate-Based N-Heterocyclic Carbenes.;Benjamin K. Keitz, et al.,;《Organometallics》;20091218;第29卷;第403-408页 *
Sugar-Incorporated N-Heterocyclic Carbene Complexes.;Takanori Nishioka, et al.,;《Organometallics》;20070130;第26卷;第1126-1128页. *
手性NHC中间体1-(2,3,4,6-四-O-乙酰基-β-D-吡喃葡萄糖基)咪唑的合成及核磁共振研究.;杨志才等,;《化工中间体》;20131231(第02期);第22-26页. *

Also Published As

Publication number Publication date
CN104761600A (en) 2015-07-08

Similar Documents

Publication Publication Date Title
CN101712645B (en) Preparation method for (2R, 4R)-4-substituted-2-piperidine carboxylic acid compound and intermediate thereof
CN101417972A (en) 3-methylene-indol-2-one derivates and preparation method thereof
CN102432485B (en) Alpha,beta-diamino acid derivative and synthetic method and application thereof
CN102391154B (en) Alpha-hydroxyl-beta-aminoketone derivatives, synthetic method and application thereof
CN104892614A (en) Synthesis method of 6H-isoindolo[2, 1-alpha]indol-6-one derivative
CN104761600B (en) Synthesis and uses of beta-1-imidazole-2,3,4,6-tetrahydroxy-D-glucopyranose bromide
CN102108089B (en) Preparation method of 2-deoxy-L-ribose
CN103242269B (en) A kind of preparation method of furfural
CN105732648B (en) The nitrogen-containing heterocycle compound and synthetic method of a kind of pyrrolo- furans
CN110590751B (en) Preparation method of 5-maleimide chromone compound
CN101928268A (en) Method for synthesizing heterocyclic acetylized compound by composite catalysis of ionic liquid and phosphoric acid
CN104761601B (en) The synthesis of the tetrasulfonic acid base D glucopyranose sulfur hydrogen salts of 1 imidazoles of β 2,3,4,6 and purposes
CN103304623B (en) Synthetic method of 6[beta],19-epoxy androstane-3,17-dione
CN102887808B (en) Preparation method of multi-substituted indanol derivatives
CN101906445B (en) Synthesis method of 2H-1-benzopyran-2-ketone derivatives
CN105237466B (en) A kind of method for synthesizing three substituted pyridine derivatives
CN107353256A (en) The method of the triazole compounds of 4 acetyl group of one pot process 1,2,3
CN103833796B (en) Prepare the method for angustose
CN104710376B (en) Method for synthesis of oxazoline derivative based on electrophilic iodocyclization reaction of propargylamide
Gómez et al. A novel entry to C-glycals via diethylzinc-mediated umpolung of π-allyl palladium derived from 1-exo-methylene 2, 3-anhydrofuranoses
CN106995428B (en) A kind of synthetic method of 6H- benzo [C] benzopyrans compounds
CN110746278B (en) Nonmetal-catalyzed method for preparing 1, 3-diketone compound based on alkynone
CN109053543A (en) A kind of preparation method of cis- 3- alkoxy -1- methylene isoindole derivatives
CN112538059B (en) Reaction method for selectively synthesizing oxazole-4-carboxylic ester
CN104892495B (en) Novel method for synthesizing pyridine-containing compounds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20191224

Address after: 334221 new hillock town, Shangrao, Jiangxi, Dexing

Patentee after: Jiangxi Dexing PARCHN Sodium VC Co., Ltd.

Address before: 221116 Key Laboratory of No. 101 Shanghai Road, Copper Mt. New District, Jiangsu, Xuzhou 106

Patentee before: Jiangsu Normal University

TR01 Transfer of patent right